Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New RNA mpox vaccine shows promise in early trial

NCT ID NCT05988203

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 33 times

Summary

This study tested a new RNA-based vaccine (BNT166a) to prevent mpox (formerly monkeypox). It involved 96 healthy adults and looked at safety and how well the vaccine triggers the immune system. The trial was completed and helps determine if the vaccine is safe enough for further testing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MONKEYPOX are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Addenbrooke's Hospital - Cambridge University Hospitals NHS Foundation Trust

    Cambridge, CB2 0QQ, United Kingdom

  • Alliance for Multispecialty Research, LLC

    Kansas City, Missouri, 64114, United States

  • Alliance for Multispecialty Research, LLC

    Knoxville, Tennessee, 37909, United States

  • California Research Foundation

    San Diego, California, 92123, United States

  • Guy's and St Thomas' NHS Foundation Trust of St Thomas' Hospital

    London, SE1 7EH, United Kingdom

  • Medicine Evaluation Unit Ltd, The Langley Building, Wythenshawe Hospital

    Manchester, M239QZ, United Kingdom

  • Royal Surrey County Hospital Foundation Trust, NIHR Royal Surrey Clinical Research Facility

    Guildford, GU2 7XP, United Kingdom

  • University Hospital Southampton

    Southampton, SO16 6YD, United Kingdom

  • University of Washington Virology Research Clinic

    Seattle, Washington, 98104, United States

Conditions

Explore the condition pages connected to this study.